# Efficacy Study of LY2422347 to Treat Insomnia

> **NCT00259311** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 400 (—)

## Conditions studied

- Sleep Initiation and Maintenance Disorders

## Interventions

- **DRUG:** LY2422347
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00259311
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-11
- **Primary completion:** —
- **Final completion:** 2006-11
- **Target enrollment:** 400 (—)
- **Last updated:** 2007-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00259311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00259311, "Efficacy Study of LY2422347 to Treat Insomnia". Retrieved via MORVS 2026-10-19 from https://api.morvs.ai/clinical/NCT00259311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*